Pre-treatment serum squamous cell carcinoma antigen [SCC] levels are elevated in 28–88%
of patients with squamous cell cervical cancer, and are related to tumour stage, tumour size …

Head and neck squamous cell carcinoma (HNSCC), as a complex and variable malignancy,
poses a significant threat to human health. Since the intricate association between HPV and …

External redox reagents and chemical mediators in measuring solutions are extensively
used to monitor the analytical signals in electrochemical immunosensors. These mediators …

Oral squamous cell carcinoma (OSCC) accounts for 90% of malignant lesions of oral cavity.
The study assessed the potential of Cyfra 21-1 as a tumor marker in OSCC. The study …

Serum biomarkers could be helpful to characterize head and neck squamous cell carcinoma
(HNSCC). Thus, the purpose of this systematic review and meta-analysis was to determine …

Cytokeratin fraction 21–1 (CYFRA 21–1) has been widely studied as an important biomarker
in non-small cell lung cancer for both diagnosis and prognosis. Many studies have also …

Tissue biopsy with histopathological examination is still considered the gold standard to
diagnose oral squamous cell carcinoma (OSCC). This systematic review explored the …

Improved therapies for individuals with head and neck squamous cell carcinoma (HNSCC)
may be developed by identification of appropriate biomarkers. The aim of this study was to …

Reduced serum-zinc concentrations are well known as typical laboratory characteristics in
advanced head and neck cancer. Our aim was to follow the development of this …

Background: Overexpression of the lysyl oxidase-like 4 (LOXL4) gene is associated with a
variety of human malignancies. The purpose of this study was to compare the gene …